Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: Clinical implications

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 50, Issue 4, 2006, Pages 363-370

  Courbon, F ^a   Caselles, O ^b   Zerdoud, S ^a   Duthill, P ^a   Regis, H ^a   Berry, I ^a   Caron, P ^a  

^a CHU RANGUEIL   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Dialysis; Iodine; Pharmacokinetics; Thyroidela neoplasms

Indexed keywords

CAPSION; IODINE 131; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD; CASE REPORT; DIALYSIS EQUIPMENT AND SUPPLIES; DOSIMETRY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG UPTAKE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION TEST; MALE; MEDICAL STAFF; NURSE; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; RADIOACTIVE CONTAMINATION; SALIVARY GLAND; STOMACH; THYROID CARCINOMA; THYROID GLAND;

ADULT; AGED, 80 AND OVER; FEMALE; HUMANS; IODINE RADIOISOTOPES; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RADIOPHARMACEUTICALS; RENAL DIALYSIS; SALIVARY GLANDS; STOMACH; THYROID GLAND; THYROID NEOPLASMS;

EID: 33846559792     PISSN: 11250135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Freitas JE, Gross MD, Ripley S, Shapiro B. Radionuclide diagnosis and therapy of thyroid cancer. J Nucl Med 1992;33:1402-05.
2. Benua RS, Cicale NR, Sonenberg M. The relation of radioiodine dosimetry to results and complication is in the treatment of metastatic thyroid cancer. AJR 1962;87:171-82.
3. Snyder WS, Ford MR, Warner GG, Watson SB. S, absorbed dose per unit cumulated activity for selected radionuclides and organs, MIRD Pamphlet N. 11. New York: The Society of Nuclear Medicine; 1975.
4. Stabin MG. Personal computer software for internal dose assessment in nuclear medicine. Nucl Med 1996;37:538-46.
5. Riggs DS. Quantitative aspects of iodine metabolism in man. Pharmacol Rev 1952;4:284-370.
6. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 1996;17:45-63.
7. M'Kacher R, Legal JD, Schlumberger M, Aubert B, Beron-Gaillard N, Gaussen A et al. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 1997;38:377-80.
8. Howard N, Glasser M. Iodine 131 ablation therapy for a patient on maintenance hemodialysis. Br J Radiol 1981;54:259.
9. Daumerie C, Vynckier S, Caussin J, Jadoul M, Squifflet JP, de Patoul N et al. Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis. Thyroid 1996;6:301-4.
10. 131I treatment of thyroid papillary carcinoma in a patient with renal failure. Cancer 1990;66:2509-13.
11. Mello AM, Isaac R, Petersen J, Kroneneberg S, Mc Couall. Management of papillary carcinoma with radioiodine in a patient with end stage renal dialysis on hemodialysis. Clin Nucl Med 1992;19:776-81.
12. Maxon HR, Thomas SR, Hertzberg VS. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983;309:937-41.
13. Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Tonshoff G, Sippel C et al. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun 1996;17:681-6.
14. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH et al., editors. UICC. TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. 3rd ed., 2nd rev. Heidelberg, New York: Springer Verlag; 1992.
15. Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF et al. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 1999;40:37S-61S.
16. Guilhem MT, Aubert B, Caselles O, Ricard M, Roger P, Touzery C. Evaluation des performance et contrôle de qualité des cameras à scintillations. Rapport SFPH n. 14 édition SFPH 1997.
17. Rouvière H. Anatomie humaine descriptive et topographique, 7ème édition. Paris: Masson et C.ie 1952;1:413-7.
18. Dolphin GW. Dietary intakes of iodine and thyroid dosimetry. Health Phys 1971;21:711-3.
19. Gadner DF, Mars DR, Thomas RC, Burungsup C, Misbin RI. Iodine retention and thyroid dysfunction in patient on hemodialysis and continual ambulatory peritoneal dialysis. Kidney 1986;7:471-6.
20. Cavalieri RR. Iodine metabolism and thyroid physiology: current concept. Thyroid 1997;7:177-81.
21. Chandra M, Clemons GK, McVicar MI. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure, J Pediatr 1988;113:1015-21.
22. Samonigg H, Kappeler AW, Fritz E. Recombinant human erythropoietin for the correction of cancer associated anaemia with and without concomitant cytotoxic chemotherapy. Cancer 1995;76:19-23.
23. Duchesne GM, Peacock JH, Steel GG. The acute in vitro and in vivo radiosensitivity of human lung tumour lines. Radiother Oncol 1986;7:353-61.
24. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Chang HR. Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis 2000;36:1110-4.
25. Shannon IL, Trodahl JN, Starcke EN. Radio sensitivity of the human parotid gland. Proc Soc Exp Biol Med 1978;157:50-3.
26. Bushnell D, Boles MA, Kaufman E, Wadas MA, Barnes WE. Complications sequels and dosimetry of iodine 131 therapy for thyroid carcinoma. J Nucl Med 1992;33:2214-21.
27. Jimenez RG, Moreno AS, Gonzales EN, Simon FJL, Rodriguez Rodriguez JR, Jimenez JC et al. Iodine 131 treatment of papillary carcinoma in patient undergoing dialysis for chronic renal failure; a dosimetric method. Thyroid 2000;11:1031-4.
28. Strand SE, Zanzonico P, Johnson TK. Pharmacokinetic modeling. Med Phys 1993;20(2 Pt 2):515-27.
29. Zanzonico PB. Internal radionuclide dosimetry: a review of basic concepts and recent developments. J Nucl Med 2000;41:291-8.
30. Nibhanupudy JR, Hamilton W, Sridhar R, Talley GB, Chughtai GM, Ashayeri E et al. Iodine-131 treatment of hyperthyroidism in a patient on dialysis for chronic renal failure. Am J Nephrol 1993;13:214-7.
31. Recommendations of the international commission on radiological protection, ICPR Publication 60. Oxford: Pergamon Press; 1991.